Just a short time ago, Hakobyan was suffering from two very serious infections, neither of which could be treated properly. The treatment he took for hepatitis C appears to have been successful … And he’s taking Bedaquiline — a new drug for drug-resistant TB — which has greatly increased his chances of survival.